Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Clovis Oncology, Inc. (NASDAQ:CLVS) today reported financial results for its second quarter ended June 30, 2013, and provided an update for its clinical development programs, including initial data presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2013.
Help employers find you! Check out all the jobs and post your resume.
